Patterns of failure among patients with squamous cell carcinoma of the head and neck who obtain a complete response to chemoradiotherapy

Head and Neck

Volumn 32, Issue 1, 2010, Pages 46-52

  Yovino, Susannah ^a   Settle, Kathleen ^a   Taylor, Rodney ^a   Wolf, Jeffrey ^a   Kwok, Young ^a   Cullen, Kevin ^a   Ord, Robert ^b   Zimrin, Ann ^a   Strome, Scott ^a   Suntharalingam, Mohan ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

Author keywords

Chemoradiation; Head and neck cancer; Neck dissection

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NECK DISSECTION; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 75149130461     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21141     Document Type: Article

References (15)

1. Brizel D, Prosnitz R, Hunter S, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;58:1418-1423.
2. Barkley H, Fletcher G, Jesse R, Lindberg R. Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx. Am J Surg 1927; 124:462-467.
3. Pignon J, Le Maitre A, Bourhis J. Meta-analyses of chemotherapy in head and neck cancer: an update. Int J Radiat Oncol Biol Phys 2007;69:S112-S114.
4. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiation therapy for organ preservation in advanced laryngeal cancer. New Eng J Med 2003; 349:2091-2098.
5. Denis F, Garaud P, Bardet E, et al. Final results of the 9401 French head and neck radiation therapy group randomized trial comparing radiation therapy alone with concomitant chemoradiation in advanced stage oropharyngeal cancer. J Clin Oncol 2004;22:69-76.
6. Brizel D, Albers M, Fisher S, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. New Eng J Med 1998;338:1798-1804.
7. Corry J, Peters L, Fisher R, et al. N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders - results of Trans-Tasman Radiation Oncology Group Study 98.02. Head Neck 2008;30:737-742.
8. Forest VI, Nguyen-Tan PF, Tabet JC, et al. Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinoma. Head Neck 2006;28: 1099-1105.
9. Grabenbauer G, Rodel C, Ernst-Stecken A, et al. Neck dissection following radiochemotherapy of advanced head and neck cancer for selected cases only? Radiother Oncol 2003;66:57-63.
10. Argiris A, Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004;26:447-455.
11. McHam SA, Adelstein DJ, Rybicki LA, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 2003;25:791-798.
12. Yeung AR, Liauw S, Amdur RJ, et al. Lymph-node-positive head and neck cancer treated with primary radiotherapy: can treatment response determine the extent of neck dissection? 2008;112:1076-1082.
13. Connell CA, Corry J, Milner AD, et al. Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma. Head Neck 2007;29:986-995.
14. Yao M, Graham MM, Hoffman HT, et al. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2004;59:1001-1010.
15. Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 2005;27:175-181.